xamoterol has been researched along with phenylbutazone in 1 studies
| Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (phenylbutazone) | Trials (phenylbutazone) | Recent Studies (post-2010) (phenylbutazone) |
|---|---|---|---|---|---|
| 269 | 80 | 17 | 6,291 | 317 | 125 |
| Protein | Taxonomy | xamoterol (IC50) | phenylbutazone (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 5.3 | |
| Cyclooxygenase-2 | Canis lupus familiaris (dog) | 3.79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
1 other study(ies) available for xamoterol and phenylbutazone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |